InvestorsHub Logo
Followers 48
Posts 2221
Boards Moderated 1
Alias Born 01/28/2013

Re: Newtoscrc post# 22372

Tuesday, 03/17/2015 12:18:52 AM

Tuesday, March 17, 2015 12:18:52 AM

Post# of 24848

Bob will need to produce an audited 10K for this conference on the 19th. If not, the conference won't go that well for SCRC. Too much of a drop in PPS recently.


A 10K would definitely be nice. But even without it, it is POSSIBLE (not saying it is PROBABLE, mind you -- simply POSSIBLE) that SCRC "may" utilize either (or both) of these conferences to announce meaningful news.

I say this because it happens quite often for companies to use these conference platform as an opportunity to really make a splash in front of potential new big-money investors.

For example, maybe an announcement about RapiMed?

Maybe an announcement about the two target acquisitions?

Who knows? But just sayin' that there is the POSSIBILITY of something unexpected being unveiled at one or both of the upcoming conferences.

Now, re: RapiMed specifically, I would say that if nothing is mentioned at the first NY conference, then RapiMed is pretty much a non-starter and folks should stop including it in any of their investment theses. If it eventually happens, then it would be a bonus. Reason I say this is that from the last PR, we should have heard follow-up news by now of actual shipment to GlobalPharmaHub as well as actual sales in Hong Kong (remember, for the second time in 2 years, BS Schneiderman has stated that regulatory approval has been obtained and that GPH is free to sell/distribute RapiMed in Hong Kong now). The ONLY possible reason for not hearing separate news on this is because SCRC "may" have been wanting to hold back and unveil it at a major investor conference. So if this NY conference comes and goes WITHOUT any mention of RapiMed, then, IMO, this pretty much confirms that NOTHING has happened with RapiMed.


The guys going to these conferences aren't stupid.


TUT's are most certainly NOT stupid.

In fact, as I stated previously, of the TUT's out there, shareholders want to cross their fingers that SCRC can garner the attention of PE (private equity) firms and NOT hedge funds. After all, it is well known in the market that HF's are primarily short-term traders who are no different than retail traders (but simply with much larger bankrolls), so they are actually the worst type of TUT that existing shareholders would want to see. PE firms are the TUT's who will take a long-term equity stake in a startup like SCRC. VC (venture capital) firms would have been nice as well, but SCRC is too far along in its evolution for VC firms to want to get involved.

So after this upcoming NY conference and the subsequent Las Vegas conference next month, be prepared for JOEY Z and his "inner circle" (LOL!) of fellow criminals to wise up and realize that touting HF's buying was actually a stupid thing to tout -- but instead begin claiming that "they have PE firm buddies who are buying..." and "I spoke with a PE firm buddy who said...", etc, etc, etc...